Koshigaya, Japan

Toshihiro Okamoto



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Toshihiro Okamoto: Pioneering Cancer Treatments

Introduction

Toshihiro Okamoto is an esteemed inventor based in Koshigaya, Japan, who has dedicated his career to advancing cancer treatment methodologies. His innovative work has led to the development of a significant patent that addresses challenging forms of cancer.

Latest Patents

Okamoto holds a notable patent for a cancer treatment composition that combines an anti-CD26 antibody with other anticancer agents. This significant invention focuses on the mesothelioma growth inhibitory effects of a standard cisplatin-pemetrexed concomitant therapy, which is further enhanced by the addition of an anti-CD26 antibody. The combination with gemcitabine demonstrates high therapeutic efficacy and excellent safety. Furthermore, by conjugating the anti-CD26 antibody (YS110) with triptolide via a divalent cross-linking agent, Okamoto has successfully created a novel antibody-drug conjugate known as Y-TR1, which shows exceptional effectiveness against CD26-positive malignant mesothelioma cells.

Career Highlights

Throughout his career at Y's Ac Co., Ltd., Toshihiro Okamoto has made substantial contributions to the field of oncology. His research emphasizes the potential for combination therapies that not only improve treatment outcomes but also prioritize patient safety. This pioneering approach in therapeutic innovation showcases Okamoto's commitment to enhancing cancer care.

Collaborations

In his research endeavors, Okamoto collaborates with notable professionals such as Taketo Yamada and Mutsumi Hayashi. Together, they amplify their expertise and contribute to transformative advancements in cancer treatment methodologies, fostering an environment of innovation and collaboration.

Conclusion

Toshihiro Okamoto stands out as a significant figure in the realm of cancer treatment innovations. Through his dedicated research and groundbreaking patent, he not only advances the fight against cancer but also solidifies his reputation as a leader in the field. His work continues to inspire further research and development in oncology, aiming to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…